| Literature DB >> 29648919 |
Heinz-Peter Gelbke1, Marcy Banton2, Christian Block3, Gordon Dawkins4, Edgar Leibold5, Mark Pemberton6, Atsunobu Sakoda7, Atsushi Yasukawa8.
Abstract
Oligomers of styrene have been identified in polystyrene (PS) polymer samples intended for food packaging. Such oligomers contribute to nonintentionally added substances (NIAS) that may migrate into food or food simulants and therefore have to be assessed for the potential risk to health. No oligomers larger than dimers and trimers of styrene have been found to be present in PS. Some in vivo and in vitro information indicative of an endocrine activity for some specific oligomers suggest concerns for their potential for endocrine disruption in humans. Data on endocrine activity available from in vitro and in vivo screening approaches and from non-guideline studies in experimental animals were evaluated. The different test methods were classified according to the OECD Conceptual Framework for Testing and Assessment of Endocrine Disruptors (OECD) and the ranking system of Borgert et al. proposed in 2014. The quality and reliability of each study is further assessed by professional judgment. The integration of the total information supports the conclusion that neither specific oligomers, nor their mixtures, potentially migrating into food are endocrine disruptors according to the definition of EFSA and WHO/IPCS.Entities:
Keywords: (anti)androgenicity; (anti)estrogenicty; NIAS in polystyrene; assessment of endocrine activity; dimers and trimers of styrene; effects on thyroid regulation; in vitro and in vivo screening tests; oligomers
Mesh:
Substances:
Year: 2018 PMID: 29648919 DOI: 10.1080/10408444.2018.1447547
Source DB: PubMed Journal: Crit Rev Toxicol ISSN: 1040-8444 Impact factor: 5.635